Typical dosing: forehead lines 10 to 30 units, glabellar frown lines 20 to 25 units, crow's feet 12 to 24 units (both sides), bunny lines 4 to 8 units, lip flip 4 to 6 units. Men typically require higher doses than women due to greater muscle mass. The exact dosage is determined during your consultation based on muscle strength and aesthetic goals.

Not when administered properly. The goal at ADSC is to reduce wrinkle-forming muscle activity while preserving natural expression. Conservative dosing and precise placement maintain brow mobility, the ability to smile naturally, and appropriate facial animation. The "frozen" look results from excessive dosing by providers focused on eliminating all movement rather than achieving a natural balance.

Initial effects appear at 3 to 5 days as the toxin binds to nerve terminals. Full clinical effect develops over 10 to 14 days as the maximum number of nerve terminals are affected. We schedule a two-week follow-up to assess the result and provide touch-up units to any areas with residual muscle activity.

Yes. Preventive Botox reduces repetitive muscle contractions that create expression lines before they become permanently etched into the skin at rest. Patients who begin treatment in their late 20s to early 30s — when dynamic lines are visible during expression but not yet present at rest — can significantly delay the progression to static wrinkles.

Botox has a 35-year safety record with over 100 million treatments administered worldwide. Long-term studies show no cumulative toxicity. The product is metabolized locally and does not accumulate in the body. Patients who have received regular treatments for 15+ years show no adverse long-term effects. The muscle may develop some degree of atrophy with prolonged use, which is considered a beneficial effect.

A lip flip involves injecting 4 to 6 units of Botox into the orbicularis oris muscle along the upper lip border. This relaxes the muscle that pulls the lip inward, allowing the upper lip to roll slightly outward and appear fuller. The effect is subtle — adding the appearance of volume without actually adding filler material. It lasts approximately 6 to 8 weeks (shorter than standard Botox areas).

Yes. Botox is FDA-approved for hyperhidrosis (excessive sweating) of the underarms. The toxin blocks the nerve signals that stimulate sweat glands. Results last 6 to 12 months — significantly longer than cosmetic applications because sweat gland innervation recovers more slowly than skeletal muscle innervation. This application is not typically offered at ADSC but can be discussed during consultation.

All three are botulinum toxin type A products that work through the same mechanism. Botox (onabotulinumtoxinA) is the most widely used with the most published safety data. Dysport (abobotulinumtoxinA) has a faster onset and broader diffusion pattern. Xeomin (incobotulinumtoxinA) contains no complexing proteins, reducing the theoretical risk of antibody formation. At ADSC, we primarily use Botox Cosmetic based on its established safety profile and predictable clinical behavior.

Eyelid ptosis (drooping) occurs in approximately 1% to 2% of cases when Botox migrates from the injection site to the levator palpebrae superioris muscle that improves the upper eyelid. The risk is minimized by precise injection technique, proper anatomical placement, and patient compliance with post-injection instructions (no rubbing, no lying flat for 4 hours). If it occurs, it is temporary and resolves within 2 to 4 weeks.

Botox is not approved for use during pregnancy or breastfeeding. No studies have demonstrated harm, but the lack of controlled data in pregnant women means the standard recommendation is to discontinue treatment during pregnancy and nursing. Resume treatment after breastfeeding is complete.

Most patients maintain best results with treatments every three to four months. As muscle atrophy develops with regular treatment, some patients can extend intervals to four to six months. Your treatment schedule is personalized based on how quickly your muscle activity returns and your desired level of wrinkle reduction.

Absolutely. Male Botox treatments have increased 400% over the past decade. Men typically require 30% to 50% higher doses than women due to greater muscle mass in the forehead and glabellar region. The aesthetic goal for men is generally a reduction in deep furrows while maintaining a strong, masculine brow position — not the arched, lifted brow often desired by female patients.

Unlike fillers, Botox cannot be reversed — the effect must wear off over 3 to 4 months. However, most concerns can be addressed with touch-up injections: adding units to areas with residual activity, or treating adjacent muscles to balance asymmetry. This is why ADSC schedules a two-week follow-up — to evaluate the result and make adjustments while the window for effective touch-up remains open.

Aminoglycoside antibiotics and neuromuscular blocking agents may potentiate Botox effects. Blood thinners increase bruising risk (not a Botox interaction per se, but relevant to the injection procedure). Inform your provider of all medications and supplements during the consultation. Most common medications do not interact with botulinum toxin.

FDA labeling recommends no more than 400 units in a three-month period across all treatment areas. Typical cosmetic treatments use 40 to 80 units total. Even patients receiving therapeutic doses for multiple areas (forehead, glabellar, crow's feet, masseter) remain well below the maximum. Overdosing is prevented by individualized treatment planning and responsible dosing protocols.